Literature DB >> 10899875

Influence of platelets and platelet microbicidal protein susceptibility on the fate of Staphylococcus aureus in an in vitro model of infective endocarditis.

R C Mercier1, M J Rybak, A S Bayer, M R Yeaman.   

Abstract

Several lines of evidence indicate that platelets protect against endovascular infections such as infective endocarditis (IE). It is highly likely that a principal mechanism of this platelet host defense role is the release of platelet microbicidal proteins (PMPs) in response to agonists generated at sites of endovascular infection. We studied the ability of platelets to limit the colonization and proliferation of Staphylococcus aureus in an in vitro model of IE. Three isogenic S. aureus strains, differing in their in vitro susceptibility to thrombin-induced platelet microbicidal protein-1 (tPMP), were used: ISP479C (parental strain; highly susceptible to tPMP [tPMP(s)]); ISP479R (transposon mutant derived from ISP479; tPMP resistant [tPMP(r)]); or 757-5 (tPMP(r) transductant of the ISP479R genotype in the ISP479 parental background). Time-kill assays and in vitro IE models were used to examine the temporal relationship between thrombin-induced platelet activation and S. aureus killing. In time-kill studies, early platelet activation (30 min prior to bacterial exposure) correlated with a significant bactericidal effect against tPMP(s) ISP479C (r(2) > 0.90, P < 0.02) but not against tPMP(r) strains, ISP479R or 757-5. In the IE model, thrombin activation significantly inhibited proliferation of ISP479C within simulated vegetations compared to strains ISP479R or 757-5 (P < 0.05). The latter differences were observed despite there being no detectable differences among the three S. aureus strains in initial colonization of simulated vegetations. Collectively, these data indicate that platelets limit intravegetation proliferation of tPMP(s) but not tPMP(r) S. aureus. These findings underscore the likelihood that platelets play an important antimicrobial host defense role in preventing and/or limiting endovascular infections due to tPMP(s) pathogens.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10899875      PMCID: PMC98414          DOI: 10.1128/IAI.68.8.4699-4705.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  In vitro antibacterial activities of platelet microbicidal protein and neutrophil defensin against Staphylococcus aureus are influenced by antibiotics differing in mechanism of action.

Authors:  Y Q Xiong; M R Yeaman; A S Bayer
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Staphylococcus aureus susceptibility to thrombin-induced platelet microbicidal protein is independent of platelet adherence and aggregation in vitro.

Authors:  M R Yeaman; D C Norman; A S Bayer
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

3.  Experimental bacterial endocarditis. 3. Production and progress of the disease in rabbits.

Authors:  D T Durack; P B Beeson; R G Petersdorf
Journal:  Br J Exp Pathol       Date:  1973-04

4.  Experimental bacterial endocarditis. I. Colonization of a sterile vegetation.

Authors:  D T Durack; P B Beeson
Journal:  Br J Exp Pathol       Date:  1972-02

Review 5.  Defensins.

Authors:  T Ganz; M E Selsted; R I Lehrer
Journal:  Eur J Haematol       Date:  1990-01       Impact factor: 2.997

Review 6.  beta-Lysin of platelet origin.

Authors:  D M Donaldson; J G Tew
Journal:  Bacteriol Rev       Date:  1977-06

Review 7.  The pathogenesis of infective endocarditis.

Authors:  L R Freedman
Journal:  J Antimicrob Chemother       Date:  1987-09       Impact factor: 5.790

8.  Partial characterization and staphylocidal activity of thrombin-induced platelet microbicidal protein.

Authors:  M R Yeaman; S M Puentes; D C Norman; A S Bayer
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

9.  Bacterial adherence in the pathogenesis of endocarditis. Interaction of bacterial dextran, platelets, and fibrin.

Authors:  W M Scheld; J A Valone; M A Sande
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

10.  3H-spiramycin penetration into fibrin vegetations in an experimental model of streptococcal endocarditis.

Authors:  A C Cremieux; J M Vallois; B Maziere; M Ottaviani; A Bouvet; C Carbon; J J Pocidalo
Journal:  J Antimicrob Chemother       Date:  1988-07       Impact factor: 5.790

View more
  12 in total

1.  Morphofunctional reaction of bacteria treated with antimicrobial peptides derived from farm animal platelets.

Authors:  Alexey S Vasilchenko; Veronica V Dymova; Olga L Kartashova; Maria V Sycheva
Journal:  Probiotics Antimicrob Proteins       Date:  2015-03       Impact factor: 4.609

2.  Single-dose oral amoxicillin or linezolid for prophylaxis of experimental endocarditis due to vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis.

Authors:  Philippe Moreillon; Walter R Wilson; Roland Leclercq; José M Entenza
Journal:  Antimicrob Agents Chemother       Date:  2007-03-12       Impact factor: 5.191

3.  Exploring platelet chemokine antimicrobial activity: nuclear magnetic resonance backbone dynamics of NAP-2 and TC-1.

Authors:  Leonard T Nguyen; Paulus H S Kwakman; David I Chan; Zhihong Liu; Leonie de Boer; Sebastian A J Zaat; Hans J Vogel
Journal:  Antimicrob Agents Chemother       Date:  2011-02-14       Impact factor: 5.191

4.  Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) function.

Authors:  George Sakoulas; George M Eliopoulos; Vance G Fowler; Robert C Moellering; Richard P Novick; Natalie Lucindo; Michael R Yeaman; Arnold S Bayer
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

5.  Platelet antistaphylococcal responses occur through P2X1 and P2Y12 receptor-induced activation and kinocidin release.

Authors:  Darin A Trier; Kimberly D Gank; Deborah Kupferwasser; Nannette Y Yount; William J French; Alan D Michelson; Leon I Kupferwasser; Yan Q Xiong; Arnold S Bayer; Michael R Yeaman
Journal:  Infect Immun       Date:  2008-09-29       Impact factor: 3.441

Review 6.  Platelet alpha-granules: basic biology and clinical correlates.

Authors:  Price Blair; Robert Flaumenhaft
Journal:  Blood Rev       Date:  2009-05-17       Impact factor: 8.250

7.  Beneficial influence of platelets on antibiotic efficacy in an in vitro model of Staphylococcus aureus-induced endocarditis.

Authors:  Renee-Claude Mercier; Robert M Dietz; Jory L Mazzola; Arnold S Bayer; Michael R Yeaman
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

Review 8.  Targeting the host hemostatic system function in bacterial infection for antimicrobial therapies.

Authors:  Yuanxi Xu; Haiqing Yu; Hongmin Sun
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

9.  Platelets kill circulating parasites of all major Plasmodium species in human malaria.

Authors:  Steven Kho; Bridget E Barber; Edison Johar; Benediktus Andries; Jeanne R Poespoprodjo; Enny Kenangalem; Kim A Piera; Anna Ehmann; Ric N Price; Timothy William; Tonia Woodberry; Simon Foote; Gabriela Minigo; Tsin W Yeo; Matthew J Grigg; Nicholas M Anstey; Brendan J McMorran
Journal:  Blood       Date:  2018-07-19       Impact factor: 25.476

Review 10.  Platelets in defense against bacterial pathogens.

Authors:  Michael R Yeaman
Journal:  Cell Mol Life Sci       Date:  2009-12-15       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.